BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34676991)

  • 1. Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.gov.
    Lai-Kwon J; Yin Z; Minchom A; Yap C
    Cancer Med; 2021 Nov; 10(22):7943-7957. PubMed ID: 34676991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review.
    Alger E; Minchom A; Lee Aiyegbusi O; Schipper M; Yap C
    EClinicalMedicine; 2023 Oct; 64():102228. PubMed ID: 37781154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum.
    Lai-Kwon J; Vanderbeek AM; Minchom A; Lee Aiyegbusi O; Ogunleye D; Stephens R; Calvert M; Yap C
    Oncologist; 2022 Sep; 27(9):768-777. PubMed ID: 35762393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers.
    Spencer K; Butenschoen H; Alger E; Bachini M; Cook N
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433648. PubMed ID: 38857456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
    Vanderhout S; Fergusson DA; Cook JA; Taljaard M
    PLoS Med; 2022 Feb; 19(2):e1003896. PubMed ID: 35134080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
    Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
    Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review.
    Patel K; Ivanov A; Jocelyn T; Hantel A; Garcia JS; Abel GA
    JAMA Netw Open; 2024 Jun; 7(6):e2414425. PubMed ID: 38829615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis.
    Steinberg BA; Dorian P; Anstrom KJ; Hess R; Mark DB; Noseworthy PA; Spertus JA; Piccini JP
    JACC Clin Electrophysiol; 2019 May; 5(5):599-605. PubMed ID: 31122382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective.
    Murugappan MN; King-Kallimanis BL; Reaman GH; Bhatnagar V; Horodniceanu EG; Bouchkouj N; Kluetz PG
    J Natl Cancer Inst; 2022 Jan; 114(1):12-19. PubMed ID: 33930159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).
    Mercieca-Bebber R; Williams D; Tait MA; Roydhouse J; Busija L; Sundaram CS; Wilson M; Langford A; Rutherford C; Roberts N; King M; Vodicka E; Devine B;
    Qual Life Res; 2018 Oct; 27(10):2581-2591. PubMed ID: 29915979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries.
    Riedl D; Rothmund M; Darlington AS; Sodergren S; Crazzolara R; de Rojas T;
    Eur J Cancer; 2021 Jul; 152():90-99. PubMed ID: 34090144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013).
    Vodicka E; Kim K; Devine EB; Gnanasakthy A; Scoggins JF; Patrick DL
    Contemp Clin Trials; 2015 Jul; 43():1-9. PubMed ID: 25896116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).
    Atherton PJ; Watkins-Bruner DW; Gotay C; Moinpour CM; Satele DV; Winter KA; Schaefer PL; Movsas B; Sloan JA
    J Pain Symptom Manage; 2015 Oct; 50(4):470-9.e9. PubMed ID: 26031708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy: A Systematic Review.
    Fabian A; Domschikowski J; Letsch A; Schmalz C; Freitag-Wolf S; Dunst J; Krug D
    JAMA Netw Open; 2022 Sep; 5(9):e2231930. PubMed ID: 36136335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Patient-Reported Outcome Measurements in Clinical Trials in China.
    Zhou H; Yao M; Gu X; Liu M; Zeng R; Li Q; Chen T; He W; Chen X; Yuan G
    JAMA Netw Open; 2022 May; 5(5):e2211644. PubMed ID: 35544134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.
    Jia Y; Li Q; Zhang X; Yan Y; Yan S; Li S; Li W; Wu X; Rong H; Liu J
    J Med Internet Res; 2024 May; 26():e45719. PubMed ID: 38718388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.
    Berkman AM; Murphy KM; Siembida EJ; Lau N; Geng Y; Parsons SK; Salsman JM; Roth ME
    Value Health; 2021 Dec; 24(12):1820-1827. PubMed ID: 34838280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
    Kluetz PG; Chingos DT; Basch EM; Mitchell SA
    Am Soc Clin Oncol Educ Book; 2016; 35():67-73. PubMed ID: 27249687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Patient-Reported Outcome Utilization Within National Clinical Trials Network Cooperative Group Radiation Oncology Trials Over the Past 2 Decades.
    Howell JN; Anker CJ; Walker AJ; Dorth JA; Kharofa JR
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1151-1160. PubMed ID: 33321191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.